4 completed. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 2 | 1 | Completed 1 |
Follow ZymoGenetics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection PEGylated recombinant interleukin 29 (PEG-rIL-29) - Hepatitis C, Chronic | Phase 1 | Completed | ZymoGenetics | 56 | 2007-12-01 | 2009-10-07 |
| Study of Recombinant Interleukin 21 in Combination With Sorafenib for Metastatic Renal Cell Carcinoma rIL-21 only, rIL-21 + sorafenib - Carcinoma, Renal Cell | Phase 1 / Phase 2 | Completed | ZymoGenetics | 52 | 2006-10-01 | 2009-05-27 |
| Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma recombinant human interleukin 21 and rituximab - Lymphoma, Non-Hodgkin | Phase 1 | Completed | ZymoGenetics | 23 | 2006-06-01 | 2008-09-05 |
| Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer Recombinant Human Interleukin-21 - Melanoma, Kidney Neoplasms | Phase 1 | Completed | ZymoGenetics | 43 | 2004-05-01 | 2009-03-09 |
Carcinoma, Renal Cell (2) · Hepatitis C (1) · Hepatitis C, Chronic (1) · Infections (1) · Kidney Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Melanoma (1) · Neoplasm Metastasis (1) · Virus Diseases (1)
Rituximab (1) · Sorafenib (1) · peginterferon lambda-1a (1)
United States (4) · Canada (1)
Diana F Hausman, MD (1) · Diana Hausman, MD (1) · Muriel Siadak, PA-C (1) · Naomi Hunder, MD (1)